Insider Trading & Ownership of Mark D. Smith
-
Location
-
Purchase, NY
-
Summary
-
The estimated net worth of Mark D. Smith is at least $2,555,849 dollars as of 11 Aug 2025. Mark D. Smith is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $1.21M. Mark D. Smith is the Director of Phreesia, Inc. and owns shares of Phreesia, Inc. (PHR) stock worth about $1.08M. Mark D. Smith is the Director of Teladoc Health, Inc. and owns shares of Teladoc Health, Inc. (TDOC) stock worth about $267K.
-
Signature
-
By: /s/Adam Guttmann, as attorney in fact For: Mark D. Smith
Follow Filing Activity
Follow Mark D. Smith and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Mark D. Smith has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,555,849.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Jazz Pharmaceuticals plc ($1,205,618).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Mark D. Smith
Insider Transactions Reported by Mark D. Smith:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.